Your session is about to expire
← Back to Search
Behavioral Intervention
Online Advance Care Planning Tool for Cognitive Impairment (Portal-Voice Trial)
N/A
Recruiting
Led By Jennifer Gabbard, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 65 years old and older
Have an active patient portal account
Must not have
Lacks decisional capacity as deemed by PCP
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months during the implementation period and up to 6 months post the implementation period
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if using an online tool can help improve discussions and documentation of advance care planning in people with memory problems during their regular doctor visits.
Who is the study for?
This trial is for community-dwelling adults with cognitive impairment who are under outpatient primary care. The study aims to include those who may benefit from improved discussions and documentation of their future healthcare preferences.
What is being tested?
The study is testing ACPVoice, a tool designed for advance care planning (ACP), against the standard of care in ACP. It will evaluate how well ACPVoice facilitates conversations and decision-making about future healthcare needs.
What are the potential side effects?
Since this trial involves an advance care planning tool rather than a medical treatment, traditional physical side effects are not expected. Participants may experience emotional or psychological responses when discussing sensitive end-of-life decisions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
Select...
I have an active account on my healthcare provider's patient portal.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My primary care doctor thinks I'm unable to make my own medical decisions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months during the implementation period and up to 6 months post the implementation period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months during the implementation period and up to 6 months post the implementation period
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Intervention Completion
Reach/Engagement
Secondary study objectives
Advance Care Planning Billing Code Usage
Advance Care Planning Documentation Rates by Primary Care Providers
Documented Designated Surrogate Decision Maker
Other study objectives
Barrier to Adoption
Digital Health Literacy
Feeling Heard and Understood
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ACPVoice InterventionExperimental Treatment1 Intervention
Community-dwelling persons living with cognitive impairment aged 65 and older with known or probable mild cognitive impairment or dementia or elevated eRADAR score (with decision-making capacity), who are affiliated with the Atrium-Wake Forest Baptist Health , have a primary care physician at one of the participating sites, and have an active patient portal account.
Group II: Standard of CareActive Control1 Intervention
Community-dwelling persons living with cognitive impairment aged 65 and older with known or probable mild cognitive impairment or dementia or elevated eRADAR score (with decision-making capacity), who are affiliated with the Atrium-Wake Forest Baptist Health, have a primary care physician within the Atrium-Wake Forest Baptist Health Network, and have an active patient portal account.
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,805 Previous Clinical Trials
28,194,557 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,478,035 Total Patients Enrolled
Jennifer Gabbard, MDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
298 Total Patients Enrolled